1. Why have neuroprotectants failed?

   • K. W. Muir
   • Ph. A. Teal

   REVIEW 25 August 2005 Pages: 1011 - 1020

2. Comparison of different MR venography techniques for detecting transverse sinus stenosis in idiopathic intracranial hypertension

   • Francesco Fera
   • Francesco Bono
   • Aldo Quattrone

   ORIGINAL COMMUNICATION 07 March 2005 Pages: 1021 - 1025

3. The use of multiattribute decision models in evaluating triptan treatment options in migraine

   • M. D. Ferrari
   • P. J. Goadsby
   • P. Williams

   ORIGINAL COMMUNICATION 11 March 2005 Pages: 1026 - 1032

4. PEN–2 gene mutation in a familial Alzheimer’s disease case

   • C. Sala Frigerio*
   • P. Piscopo*
   • A. Confaloni

   ORIGINAL COMMUNICATION 16 March 2005 Pages: 1033 - 1036

5. Increasing normal–appearing grey and white matter magnetisation transfer ratio abnormality in early relapsing–remitting multiple sclerosis

   • G. R. Davies
   • D. R. Altmann
   • D. H. Miller

   ORIGINAL COMMUNICATION 18 April 2005 Pages: 1037 - 1044

6. Different clinical and evolutional patterns in late idiopathic and vascular parkinsonism

   • L. Rampello
   • A. Alvano
   • M. Malaguarnera

   ORIGINAL COMMUNICATION 06 June 2005 Pages: 1045 - 1049

7. Effects of carotid endarterectomy on motor evoked potentials elicited by transcranial magnetic stimulation

   • G. Katsoulas
   • I. Tsolakis
   • E. Chroni

   ORIGINAL COMMUNICATION 20 May 2005 Pages: 1050 - 1054

8. Gastric emptying after semi–solid food in multiple system atrophy and Parkinson disease

   • T. Thomaides
   • T. Karapanayiotides
   • I. Zaloni

   ORIGINAL COMMUNICATION 04 April 2005 Pages: 1055 - 1059

9. Development and evaluation of the Parkinson Psychosis Questionnaire

   • D. Brandstaedter
   • S. Spieker
   • K. Eggert

   ORIGINAL COMMUNICATION 01 April 2005 Pages: 1060 - 1066

10. Isolated blood–cerebrospinal fluid barrier dysfunction: prevalence and associated diseases

    • J. Brettschneider
    • A. Claus
    • H. Tumani

    ORIGINAL COMMUNICATION 01 April 2005 Pages: 1067 - 1073

11. Effects of levodopa oral bolus on the kinematics of the pointing movements in Parkinson’s disease patients

    • R. Camarda
    • C. Camarda
    • M. Gangitano

    ORIGINAL COMMUNICATION 14 April 2005 Pages: 1074 - 1081

12. Metabolic characteristics of cortical malformations causing epilepsy

    • S. G. Mueller
    • K. D. Laxer
    • M. W. Weiner

    ORIGINAL COMMUNICATION 29 April 2005 Pages: 1082 - 1092

13. Common carotid artery intima–media thickness for the risk assessment of lacunar infarction versus intracerebral haemorrhage

    • G. Tsivgoulis
    • K. N. Vemmos
    • M. Mavrikakis

    ORIGINAL COMMUNICATION 23 May 2005 Pages: 1093 - 1100

14. Sensorineural hearing loss in patients with chronic progressive external ophthalmoplegia or Kearns–Sayre syndrome

    • C. Kornblum
    • R. Broicher
    • R. Schröder

    ORIGINAL COMMUNICATION 15 April 2005 Pages: 1101 - 1107

15. Methodological quality of animal studies on neuroprotection in focal cerebral ischaemia

    • H. Bart van der Worp
    • Peter de Haan
    • Cor J. Kalkman

    ORIGINAL COMMUNICATION Pages: 1108 - 1114

16. Clinical trials are too often founded on poor quality pre–clinical research

    • P. M. Rothwell

    LETTER TO THE EDITORS 24 March 2005 Pages: 1115 - 1115

17. Parkinsonism–hyperpyrexia syndrome not related to antiparkinsonian treatment withdrawal during the 2003 summer heat wave

    • C. Gaig
    • M. J. Martí
    • S. Amaro

    LETTER TO THE EDITORS 21 March 2005 Pages: 1116 - 1119

18. Medical treatment for nocardial brain abscesses

    • M. Braga
    • S. Beretta
    • V. Crespi

    LETTER TO THE EDITORS 29 March 2005 Pages: 1120 - 1121

19. Recurrent spontaneous ”neuroleptic malignant syndrome” in the absence of neuroleptic medication in probable dementia with Lewy bodies

    • K. E. Weber
    • R. A. Linker
    • J. Classen

    LETTER TO THE EDITORS 14 March 2005 Pages: 1122 - 1124

20. Spastic paraparesis as a manifestation of metabolic vitamin B12 deficiency

    • S.–H. Cheng
    • M.–H. Chang
    • Y.–C. Lee

    LETTER TO THE EDITORS 01 April 2005 Pages: 1125 - 1126

21. Lambert–Eaton Myasthenic syndrome associated with sarcoidosis

    • F. Purroy García
    • M. Comabella
    • X. Montalban

    LETTER TO THE EDITORS 20 April 2005 Pages: 1127 - 1128

22. Neurosyphilis and paraneoplastic limbic encephalitis: important differential diagnoses

    • R. Scheid
    • R. Voltz
    • D. Y. von Cramon

    LETTER TO THE EDITORS 01 April 2005 Pages: 1129 - 1132

23. Primary Central Nervous System Lymphoma (PCNSL) occurring in pregnancy

    • D. O’Mahony
    • A. Ryan Abdul Razak
    • L. Grogan

    LETTER TO THE EDITORS 11 July 2005 Pages: 1133 - 1134

24. Adolf Wallenberg (1862–1949)

    • D. Hydén
    • B. Norrving

    PIONEERS IN NEUROLOGY Pages: 1135 - 1136

25. Handbook of Headache, Second Edition

    • Nicola Giffin

    BOOK REVIEW Pages: 1138 - 1138

26. Cerebral metabolic correlates of four dementia scales in Alzheimer’s disease

    • E. Salmon*
    • S. Lespagnard*
    • G. Garraux

    ERRATUM 28 June 2005 Pages: 1138 - 1138

27. Mutations in voltage-gated sodium channels in familial hemiplegic migraine, erythromelalgia, and other disorders

    • Michael Strupp

    JOURNAL CLUB Pages: 1139 - 1141

28. Communications of the European Neurological Society

    COMMUNICATIONS Pages: 1143 - 1146